Videos / An update on semaglutide for CKD in the presence of T2D
In this Product Explainer, Endocrinologist Prof Richard MacIsaac provides an update on the chronic kidney disease (CKD) indication for semaglutide, explains the PBS criteria and how healthcare professionals can initiate this GLP-1 RA.

Fatty Liver, CV Risk, and Post-Menopause

Paediatric Constipation & Related Issues

Management of Skin Tear in General Practice

Migraine vs Chronic Daily Headache

expert
Endocrinologist, Director, St Vincent’s Hospital Melbourne; Professor, University of Melbourne